| Literature DB >> 28744224 |
Ying Chen1, Sydney R McCauley1, Sally E Johnson1, Robert P Rhoads1, Samer W El-Kadi1.
Abstract
Low-birth-weight (LBWT) neonates experience restricted muscle growth in their perinatal life. Our aim was to investigate the mechanisms that contribute to slower skeletal muscle growth of LBWT neonatal pigs. Twenty-four 1-day old male LBWT (816 ± 55 g) and normal-birth-weight (NBWT; 1,642 ± 55 g) littermates (n = 12) were euthanized to collect blood and longissimus dorsi (LD) muscle subsamples. Plasma glucose, insulin, and insulin-like growth factor-I (IGF-I) were lower in LBWT compared with NBWT pigs. Muscle IGF-I mRNA expression were lower in LBWT than NBWT pigs. However, IGF-I receptor mRNA and protein abundance was greater in LD of LBWT pigs. Abundance of myostatin and its receptors, and abundance and phosphorylation of smad3 were lower in LBWT LD by comparison with NBWT LD. Abundance of eukaryotic initiation factor (eIF) 4E binding protein 1 and mitogen-activated protein kinase-interacting kinases was lower in muscle of LBWT pigs compared with NBWT siblings, while eIF4E abundance and phosphorylation did not differ between the two groups. Furthermore, phosphorylation of ribosomal protein S6 kinase 1 (S6K1) was less in LBWT muscle, possibly due to lower eIF3e abundance. In addition, abundance and phosphorylation of eIF4G was reduced in LBWT pigs by comparison with NBWT littermates, suggesting translation initiation complex formation is compromised in muscle of LBWT pigs. In conclusion, diminished S6K1 activation and translation initiation signaling are likely the major contributors to impaired muscle growth in LBWT neonatal pigs. The upregulated IGF-I R expression and downregulated myostatin signaling seem to be compensatory responses for the reduction in protein synthesis signaling.Entities:
Keywords: IGF-I; low-birth-weight; myostatin; skeletal muscle growth; translation initiation
Year: 2017 PMID: 28744224 PMCID: PMC5504233 DOI: 10.3389/fphys.2017.00482
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Nucleotide sequences of primers used for quantitative real-time PCR.
| Forward | 5′- GTA ACC CGT TGA ACC CCA T -3′ | ||
| Reverse | 5′- CCA TCC AAT CGG TAG TAG CG -3′ | ||
| Forward | 5′- GCA CAT CAC ATC CTC TTC GC -3′ | ||
| Reverse | 5′- ACC CTG TGG GCT TGT TGA AA -3′ | ||
| Forward | 5′- CAT ACC AGG GCT TGT CCA AC -3′ | ||
| Reverse | 5′- ATC AGC TCA AAC AGC ATG TCG -3′ | ||
| Forward | 5′- GAA AGG GGG CAA GGG TCT AC -3′ | ||
| Reverse | 5′- CTC GGG TGC TTT GTT CTC CT -3′ | ||
| Forward | 5′- GCT CGT CTT CTT GGC CTT G -3′ | ||
| Reverse | 5′- CCG GCC TGC TGA AGT AGA A -3′ | ||
| Forward | 5′- CCA GAG AGA TGA CAG CAG TGA TG-3′ | ||
| Reverse | 5′- TTC CTT CCA CTT GCA TTA GAA GAT C-3′ | ||
| Forward | 5′- GGC AGA GCT GTG AAG CCT TA-3′ | ||
| Reverse | 5′- TGA TGC CTT CCT GCT GAC TG-3′ | ||
| Forward | 5′- GCA TCG CAA GCC TCC CTA T-3′ | ||
| Reverse | 5′- CTG TAG CAG GTT CTC GTG CTT C-3′ | ||
| Forward | 5′- ATC TCA GCT TTG AGG GCT CC-3′ | ||
| Reverse | 5′- TGT CCA GAC CCA AAT CAG AAC AT-3′ | ||
| Forward | 5′- CCC ATG TAA AGA AAC GTG CGA G-3′ | ||
| Reverse | 5′- TGC GGT AGG TTT TCC CAT CC-3′ |
Information of primary antibodies used for western blot.
| ALK5 | #AF3025; R&D systems, Minneapolis, MN |
| ActRIIB | #AF339; R&D systems, Minneapolis, MN |
| 4EBP1 | #A300-501A; Bethyl Laboratories, Montgomery, TX |
| eIF3e | #AB1114851; Abcam, Cambridge, MA |
| eIF4E | #9742; Cell Signaling Technology, Danvers, MA |
| eIF4G | #8701; Cell Signaling Technology, Danvers, MA |
| ERK1/2 | #4695; Cell Signaling Technology, Danvers, MA |
| IGF-I receptor β | #9750; Cell Signaling Technology, Danvers, MA |
| MNK1 | #2195; Cell Signaling Technology, Danvers, MA |
| MNK2 | #sc-271559; Santa Cruz Biotechnology, Dallas, TX |
| Myostatin | #AB3239-I; Millipore, Temecula, CA |
| mTOR | #2983; Cell Signaling Technology, Danvers, MA |
| phospho-mTOR (Ser2481) | #2974; Cell Signaling Technology, Danvers, MA |
| p70 S6 kinase | #2708; Cell Signaling Technology, Danvers, MA |
| phospho-4EBP1 (Thr46) | #44-1170G; Invitrogen, Camarillo, CA |
| phospho-eIF4E (Ser209) | #9741; Cell Signaling Technology, Danvers, MA |
| phospho-ERK1/2 (Thr202/Tyr204) | #4370; Cell Signaling Technology, Danvers, MA |
| phospho-MNK1 (Thr197/202) | #2111; Cell Signaling Technology, Danvers, MA |
| phospho-PKB/Akt (Ser473) | #9271; Cell Signaling Technology, Danvers, MA |
| phosphor-eIF4G (Ser1108) | #2441; Cell Signaling Technology, Danvers, MA |
| phospho-S6K1 (Thr389) | #07-018-I; Millipore, Temecula, CA |
| phospho-smad2 (Ser465/467)/smad3 (Ser423/425) | #8828; Cell Signaling Technology, Danvers, MA |
| PKB/Akt | #9272; Cell Signaling Technology, Danvers, MA |
| Smad2/3 | #8685; Cell Signaling Technology, Danvers, MA |
| α-Tubulin | #3873; Cell Signaling Technology, Danvers, MA |
Figure 1Plasma insulin-like growth factor (IGF)-I (A), insulin (B), and glucose (C) concentration in low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. Results are means ± SE. n = 12. Values with different letters differ significantly (P ≤ 0.05).
Figure 2Gene expression of insulin-like growth factor (IGF) system in longissimus dorsi muscle of low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. (A–D): Relative mRNA expression of IGF-I, IGF-II, IGF-I receptor (IGF-I R), and insulin receptor (INSR). Results are means ± SE. n = 12. Values with different letters differ significantly (P ≤ 0.05).
Figure 3Protein abundance of IGF-I receptor (IGF-I R) in longissimus dorsi muscle of low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. (A): Representative western blot images from four pairs of NBWT and LBWT pigs (N, NBWT; L, LBWT). (B): Abundance of IGF-I R was normalized to α-tubulin. Results are means ± SE. n = 12. Values with different letters differ significantly (P ≤ 0.05).
Figure 4Protein abundance and phosphorylation of PKB/Akt and mTOR in longissimus dorsi muscle of low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. (A): Representative western blots from four pairs of LBWT and NBWT pigs (N, NBWT; L, LBWT). (B–E): Protein abundance and phosphorylation of PKB/Akt and mTOR. Abundance was normalized to α-tubulin and phosphorylation normalized to the corresponding non-phospho-proteins. Results are means ± SE. n = 12.
Figure 5Protein abundance and phosphorylation of 4EBP1 and S6K1 in longissimus dorsi muscle of low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. (A): Representative western blots from four pairs of LBWT and NBWT pigs (N, NBWT; L, LBWT). (B–E): Protein abundance and phosphorylation of 4EBP1 and S6K1. Abundance was normalized to α-tubulin and phosphorylation normalized to the corresponding non-phospho-proteins. Results are means ± SE. n = 12. Values with different letters differ significantly (P ≤ 0.05).
Figure 6Protein abundance and phosphorylation of ERK1/2 in longissimus dorsi muscle of low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. (A): Representative western blots from four pairs of LBWT and NBWT pigs (N, NBWT; L, LBWT). (B–E): Protein abundance and phosphorylation of ERK1 and ERK2. Abundance was normalized to α-tubulin and phosphorylation normalized to the corresponding non-phospho-proteins. Results are means ± SE. n = 12.
Figure 7Protein abundance and phosphorylation of MNK1/2 in longissimus dorsi muscle of low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. (A): Representative western blots from four pairs of LBWT and NBWT pigs (N, NBWT; L, LBWT). (B–E): Protein abundance and phosphorylation of MNK1 and MNK2. Abundance was normalized to α-tubulin and phosphorylation normalized to the corresponding non-phospho-proteins. Results are means ± SE. n = 12. Values with different letters differ significantly (P ≤ 0.05).
Figure 8Translation initiation signaling in longissimus dorsi muscle of low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. (A): Representative western blots from four pairs of LBWT and NBWT pigs (N, NBWT; L, LBWT). (B–F): Protein abundance and phosphorylation of eIF4E, eIF4G, and protein abundance of eIF3e. Abundance was normalized to α-tubulin and phosphorylation normalized to the corresponding non-phospho-proteins. Results are means ± SE. n = 12. Values with different letters differ significantly (P ≤ 0.05).
Figure 9Gene expression of myostatin (MSTN) system in longissimus dorsi skeletal muscle from low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. (A–E): Relative mRNA expression of MSTN, MSTN receptors, decorin, and follistatin (FST). Results are means ± SE. n = 12. Values with different letters differ significantly (P ≤ 0.05).
Figure 10Myostatin signaling in longissimus dorsi muscle of low-birth-weight (LBWT) and normal-birth-weight (NBWT) neonatal pigs. (A): Representative western blots from four pairs of LBWT and NBWT pigs (N, NBWT; L, LBWT). (B–G): Protein abundance of myostain, ALK5 and ActRIIB, and protein abundance phosphorylation of smad2/3. Abundance was normalized to α-tubulin and phosphorylation normalized to the corresponding non-phospho-proteins. Results are means ± SE. n = 12. Values with different letters differ significantly (P ≤ 0.05).